BCLI OTC
Brainstorm Cell Therapeutics Inc.
1W: -4.1%
1M: -26.8%
3M: -28.4%
YTD: +52.5%
1Y: +31.0%
3Y: -84.1%
5Y: -98.2%
$0.93
-0.07 (-6.98%)
Weekly Expected Move ±11.5%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
-100.0% YoY
$-11M
Net Income
+8.1% YoY
$-4M
Free Cash Flow
+57.2% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE119.2%
ROA-692.7%
ROIC76.7%
Valuation
P/E-1.0
P/B-0.9
EV/EBITDA-1.3
Leverage
Debt/Equity-0.12
Current Ratio0.03
Interest Cov.-1421.4x
Quality Scores
Piotroski F1/9
Altman Z-820.26
Beneish M0.00